Comparison between CHA2DS2-VASc and the new R2CHADS2 and ATRIA scores at predicting thromboembolic event in non-anticoagulated and anticoagulated patients with non-valvular atrial fibrillation

BMC Cardiovascular Disorders

Volumn 15, Issue 1, 2015, Pages

  Abumuaileq, Rami Riziq Yousef ^a   Abu Assi, Emad ^a   López López, Andrea ^a   Raposeiras Roubin, Sergio ^a   Rodríguez Mañero, Moisés ^a   Martínez Sande, Luis ^a   García Seara, Javier ^a   Fernandez López, Xesús Alberte ^a   Peña Gil, Carlos ^a   González Juanatey, Jose Ramón ^a  

^a University Hospital of Santiago de Compostela   (Spain)

Author keywords

Anticoagulant; Atrial fibrillation; Thromboembolism

Indexed keywords

ANTICOAGULANT AGENT; ANTIVITAMIN K;

AGED; ANTICOAGULANT THERAPY; ANTICOAGULATION AND RISK FACTORS IN ATRIAL FIBRILLATION SCORE; ARTICLE; ATRIAL FIBRILLATION; BRAIN ISCHEMIA; COMPARATIVE STUDY; CONGESTIVE HEART FAILURE HYPERTENSION AGE DIABETES MELLITUS PRIOR STROKE OR TRANSIENT ISCHEMIC ATTACK VASCULAR DISEASE SCORE; CONTROLLED STUDY; FATALITY; FEMALE; FOLLOW UP; HUMAN; LOW RISK PATIENT; MAJOR CLINICAL STUDY; MALE; NON-VALVULAR ATRIAL FIBRILLATION; OUTCOME ASSESSMENT; PATIENT IDENTIFICATION; PRIORITY JOURNAL; RENAL DYSFUNCTION CONGESTIVE HEART FAILURE HYPERTENSION AGE DIABETES MELLITUS PRIOR STROKE OR TRANSIENT ISCHEMIC ATTACK SCORE; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SCORING SYSTEM; THROMBOEMBOLISM; TRANSIENT ISCHEMIC ATTACK; TREATMENT OUTCOME; COMPLICATION; MIDDLE AGED; PROCEDURES; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ANTICOAGULANTS; ATRIAL FIBRILLATION; FEMALE; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK ASSESSMENT; THROMBOEMBOLISM;

EID: 84947779709     PISSN: None     EISSN: 14712261     Source Type: Journal    
DOI: 10.1186/s12872-015-0149-3     Document Type: Article

References (21)

1. Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: the Framingham study. Stroke. 1991;22:983-8.
2. Hart RG, Benavente O, McBride R, Pearce LA. Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: a meta-analysis. Ann Intern Med. 1999;131:492-501.
3. Wann LS, Curtis AB, January CT, Ellenbogen KA, Lowe JE, Estes NA3rd, et al. 2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (updating the 2006 guideline): a report of the American College of Cardiology Foundation/ American Heart Association task force on practice guidelines. J Am Coll Cardiol. 2011;57:223-42.
4. You JJ, Singer DE, Howard PA, Lane DA, Eckman MH, Fang MC, et al. Antithrombotic therapy for atrial fibrillation: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2012;141:e531S-75.
5. Camm AJ, Lip GY, De Caterina R, Atar D, Hohnloser SH, Hindricks G, et al. 2012 focused update of the ESC guidelines for the management of atrial fibrillation: an update of the 2010 ESC guidelines for the management of atrial fibrillation-developed with the special contribution of the European Heart Rhythm Association. Europace. 2012;14:1385-413.
6. Gage BF, Waterman AD, Shannon W, Boechler M, Rich MW, Radford MJ. Validation of clinical classification schemes for predicting stroke: results from the national registry of atrial fibrillation. JAMA. 2001;285:2864-70.
7. Lip GY, Nieuwlaat R, Pisters R, Lane DA, Crijns HJ. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. Chest. 2010;137:263-72.
8. 2 score 0-1: a nationwide cohort study. Thromb Haemost. 2012;107:1172-9.
9. 2 of 1 who are unlikely to benefit from oral anticoagulant therapy. Eur Heart J. 2013;34:170-6.
10. Van Staa TP, Setakis E, Di Tanna GL, Lane DA, Lip GY. A comparison of risk stratification schemes for stroke in 79,884 atrial fibrillation patients in general practice. J Thromb Haemost. 2011;9:39-48.
11. Fang MC, Go AS, Chang Y, Borowsky L, Pomernacki NK, Singer DE, et al. Comparison of risk stratification schemes to predict thromboembolism in people with nonvalvular atrial fibrillation. J Am Coll Cardiol. 2008;51:810-5.
12. Chao TF, Liu CJ, Wang KL, Lin YJ, Chang SL, Lw L, et al. Using the CHA2DS2-VASc score for refining stroke risk stratification in 'low-risk' asian patients with atrial fibrillation. J Am Coll Cardiol. 2014;64:1658-65.
13. 2 index in the ROCKET AF (Rivaroxaban Once-Daily, Oral, Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation) and ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) study cohorts. Circulation. 2013;127:224-32.
14. Singer DE, Chang Y, Borowsky LH, Fang MC, Pomernacki NK, Udaltsova N, et al. A new risk scheme to predict ischemic stroke and other thromboembolism in atrial fibrillation: the ATRIA study stroke risk score. J Am Heart Assoc. 2013;2:e000250.
15. Dzeshka MS, Lane DA, Lip GY. Stroke and bleeding risk in atrial fibrillation: navigating the alphabet soup of risk-score acronyms (CHADS2, CHA2DS2-VASc, R2CHADS2, HAS-BLED, ATRIA, and More). Clin Cardiol. 2014;37:634-44.
16. Abumuaileq RR, Abu-Assi E, Raposeiras-Roubin S, Lopez-Lopez A, Redondo-Dieguez A, Alvarez-Iglesias D, et al. Evaluation of SAMe-TT2R2 risk score for predicting the quality of anticoagulation control in a real-world cohort of patients with non-valvular atrial fibrillation on vitamin-K antagonists. Europace. 2015;17:711-7.
17. Levey AS, Coresh J, Greene T, Marsh J, Stevens LA, Kusek JW, et al. Expressing the modification of diet in renal disease study equation for estimating glomerular filtration rate with standardized serum creatinine values. Clin Chem. 2007;53:766-72.
18. Baber U, Howard VJ, Halperin JL, Soliman EZ, Zhang X, McClellan W, et al. Association of chronic kidney disease with atrial fibrillation among adults in the united states. Reasons for Geographic and Racial Differences in Stroke (REGARDS) study. Circ Arrhythm Electrophysiol. 2011;4:26-32.
19. Rose AJ, Hylek EM, Ozonoff A, Ash AS, Reisman JI, Berlowitz DR. Patient characteristics associated with oral anticoagulation control: results of the Veterans AffaiRs Study to Improve Anticoagulation (VARIA). J Thromb Haemost. 2010;8:2182-91.
20. Lip GY, Frison L, Halperin JL, Lane DA. Identifying patients at high risk for stroke despite anticoagulation: a comparison of contemporary stroke risk stratification schemes in an anticoagulated atrial fibrillation cohort. Stroke. 2010;41:2731-8.
21. Hart RG, Pearce LA, Aguilar MI. Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Ann Intern Med. 2007;146:857-67.